Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Antibiotics: Combatting Tolerance To Stop Resistance.

Windels EM, Michiels JE, Van den Bergh B, Fauvart M, Michiels J.

MBio. 2019 Sep 10;10(5). pii: e02095-19. doi: 10.1128/mBio.02095-19.

2.

Bacterial persistence promotes the evolution of antibiotic resistance by increasing survival and mutation rates.

Windels EM, Michiels JE, Fauvart M, Wenseleers T, Van den Bergh B, Michiels J.

ISME J. 2019 May;13(5):1239-1251. doi: 10.1038/s41396-019-0344-9. Epub 2019 Jan 15.

PMID:
30647458
3.

Molecular mechanisms and clinical implications of bacterial persistence.

Michiels JE, Van den Bergh B, Verstraeten N, Michiels J.

Drug Resist Updat. 2016 Nov;29:76-89. doi: 10.1016/j.drup.2016.10.002. Epub 2016 Oct 15. Review.

PMID:
27912845
4.

Draft genome sequence of Enterococcus faecium strain LMG 8148.

Michiels JE, Van den Bergh B, Fauvart M, Michiels J.

Stand Genomic Sci. 2016 Sep 7;11(1):63. doi: 10.1186/s40793-016-0187-1. eCollection 2016.

5.

Draft genome sequence of Acinetobacter baumannii strain NCTC 13423, a multidrug-resistant clinical isolate.

Michiels JE, Van den Bergh B, Fauvart M, Michiels J.

Stand Genomic Sci. 2016 Sep 1;11(1):57. doi: 10.1186/s40793-016-0181-7. eCollection 2016.

6.

Frequency of antibiotic application drives rapid evolutionary adaptation of Escherichia coli persistence.

Van den Bergh B, Michiels JE, Wenseleers T, Windels EM, Boer PV, Kestemont D, De Meester L, Verstrepen KJ, Verstraeten N, Fauvart M, Michiels J.

Nat Microbiol. 2016 Mar 7;1:16020. doi: 10.1038/nmicrobiol.2016.20.

PMID:
27572640
7.

Should we develop screens for multi-drug antibiotic tolerance?

Van den Bergh B, Michiels JE, Fauvart M, Michiels J.

Expert Rev Anti Infect Ther. 2016 Jul;14(7):613-6. doi: 10.1080/14787210.2016.1194754. Epub 2016 Jun 8. No abstract available.

PMID:
27227426
8.

In Vitro Emergence of High Persistence upon Periodic Aminoglycoside Challenge in the ESKAPE Pathogens.

Michiels JE, Van den Bergh B, Verstraeten N, Fauvart M, Michiels J.

Antimicrob Agents Chemother. 2016 Jul 22;60(8):4630-7. doi: 10.1128/AAC.00757-16. Print 2016 Aug.

9.

Experimental Evolution of Escherichia coli Persister Levels Using Cyclic Antibiotic Treatments.

Van den Bergh B, Michiels JE, Michiels J.

Methods Mol Biol. 2016;1333:131-43. doi: 10.1007/978-1-4939-2854-5_12.

PMID:
26468106
10.

Obg and Membrane Depolarization Are Part of a Microbial Bet-Hedging Strategy that Leads to Antibiotic Tolerance.

Verstraeten N, Knapen WJ, Kint CI, Liebens V, Van den Bergh B, Dewachter L, Michiels JE, Fu Q, David CC, Fierro AC, Marchal K, Beirlant J, Versées W, Hofkens J, Jansen M, Fauvart M, Michiels J.

Mol Cell. 2015 Jul 2;59(1):9-21. doi: 10.1016/j.molcel.2015.05.011. Epub 2015 Jun 4.

Supplemental Content

Loading ...
Support Center